Matthew McManus is the President of Diagnostics and Genomics at Bio-Techne Corporation, a leading global life sciences company. In his role, McManus oversees the strategic direction and operational execution of Bio-Techne's diagnostics and genomics business segments. He brings extensive experience in the life sciences industry, having held various leadership positions throughout his career. Prior to joining Bio-Techne, McManus served as the President of Protein Platforms at Bio-Rad Laboratories, where he led the company's protein research and diagnostics businesses. During his tenure, he successfully launched several innovative products and drove significant growth in the company's life science and clinical diagnostics markets. McManus also held leadership roles at Affymetrix, a pioneer in microarray technology, and at Invitrogen, a major supplier of life science research tools. At Bio-Techne, McManus has been instrumental in expanding the company's diagnostics and genomics offerings through strategic acquisitions and partnerships. Under his leadership, the company has strengthened its position in the molecular diagnostics market and has made significant investments in next-generation sequencing and spatial biology technologies. McManus's expertise and vision have been crucial in driving Bio-Techne's growth and innovation in the life sciences industry.